These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8460845)

  • 41. Peripheral infusion ports for central venous access in patients with gynecologic malignancies.
    Cunningham MJ; Collins MB; Kredentser DC; Malfetano JH
    Gynecol Oncol; 1996 Mar; 60(3):397-9. PubMed ID: 8774645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Central venous indwelling catheter systems in pediatric oncology from the surgical viewpoint].
    Petersen C; Fuchs J; Kotzur A; Strauss G
    Klin Padiatr; 1998; 210(2):65-9. PubMed ID: 9561959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Port device central venous access in children with chronic renal disease--personal experience].
    Szczepańska M; Szprynger K; Stoksik P; Morawiec-Knysak A; Adamczyk P; Ziora K; Oswiecimska J
    Wiad Lek; 2006; 59(11-12):814-8. PubMed ID: 17427497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Implanted venous access system in oncology. Review of 296 cases].
    Guenier C; Nogaret JM; Ferreira J; Lorent I; Pector JC
    Ann Chir; 1990; 44(5):388-91. PubMed ID: 2372203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interventional radiology in the provision and maintenance of long-term central venous access.
    Lyon SM; Given M; Marshall NL
    J Med Imaging Radiat Oncol; 2008 Feb; 52(1):10-7. PubMed ID: 18373820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
    Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC
    Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vascular access in neonates and infants--indications, routes, techniques and devices, complications.
    Möller JC; Reiss I; Schaible T
    Intensive Care World; 1995 Jun; 12(2):48-53. PubMed ID: 10150755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subcutaneously implanted central venous access device infection in pediatric patients with cancer.
    Hung MC; Chen CJ; Wu KG; Hung GY; Lin YJ; Tang RB
    J Microbiol Immunol Infect; 2009 Apr; 42(2):166-71. PubMed ID: 19597650
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome.
    Mouw E; Chessman K; Lesher A; Tagge E
    J Pediatr Surg; 2008 Jun; 43(6):1025-9. PubMed ID: 18558177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Sepsis in children using venous implants with reservoir].
    Muguerza R; Gutiérrez JM; Gámez M; de Agustín JC; Murcia J; Utrilla JG
    Cir Pediatr; 1991 Jan; 4(1):19-22. PubMed ID: 2043429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms.
    Puig-la Calle J; López Sánchez S; Piedrafita Serra E; Allende Honorato L; Artigas Raventós V; Puig la Calle J
    J Surg Oncol; 1996 Aug; 62(4):273-8. PubMed ID: 8691841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Percutaneous implant of Hickman catheters and reservoirs. Long-term experience].
    Carreira Villamor JM; Reyes Pérez R; Pulido-Duque JM; Gorriz Gómez E; Pardo MD; Argiles Vives JM; Eyheremendy EP; Maynar Moliner M
    Rev Clin Esp; 1997 Nov; 197(11):740-4. PubMed ID: 9547192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of peripherally inserted central catheters in the management of recalcitrant maxillofacial infection.
    Islam S; Loewenthal MR; Hoffman GR
    J Oral Maxillofac Surg; 2008 Feb; 66(2):330-5. PubMed ID: 18201618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Central venous totally implantable access for high dose chemotherapy in children].
    Conter C; Carausu L; Martin E; Rubie H; Castex MP; Marec-Berard P
    Arch Pediatr; 2006 Mar; 13(3):256-61. PubMed ID: 16469486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical experience with the use of implantable vascular systems in advanced heart failure].
    Galli M; Politi A; Tettamanti F; Bonatti R; Zerboni S; Ferrari G
    G Ital Cardiol; 1996 Sep; 26(9):1005-12. PubMed ID: 9036038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Central venous access: our experience with Hickman and Broviac catheter in children].
    Milanović D; Krstić Z; Vukadinović V
    Srp Arh Celok Lek; 1994; 122(5-6):189-91. PubMed ID: 17977427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Totally implantable central venous systems in neoplastic patients].
    Costantini R; Napolitano L; Scurti D; Innocenti P
    Ann Ital Chir; 1997; 68(3):357-60. PubMed ID: 9454549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The Hickman catheter in bone marrow transplantation, long-term cytostatic and infusion therapy. Experience of 102 catheters in children].
    Welter HF; Wischhöfer E; Pfeifer KJ; Bender-Götze C
    Chirurg; 1987 Mar; 58(3):166-71. PubMed ID: 3107937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Complications of the use of implantable reservoirs of central venous access++ in pediatrics: causes and treatment].
    Pérez Martínez A; Martínez Ibáñez V; Ezzedine M
    Cir Pediatr; 1993 Apr; 6(2):59-62. PubMed ID: 8357723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders.
    Komvilaisak P; Connolly B; Naqvi A; Blanchette V
    Haemophilia; 2006 Dec; 12 Suppl 6():87-93. PubMed ID: 17123400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.